Dr. Hamidieh:
By using of stem cell technology, significant progress has been made in the field of reproductive biology and innovative treatments for infertility in men and women.
Academic standing of Iran in the field of stem cells and regenerative medicine has a significant growth in recent years and publication of scientific articles in prestigious international journals has a favorable increase.
Dr. Hamidieh: Expansion of stem cell science centers in Iran is one of our achievements in vice presidency for science and technology in the last two years
Expansion of stem cell science centers in Iran is one of our achievements in vice presidency of science and technology in the last two years So that now all the provinces of our country have been quite active in this area. By support of vice presidency of science and technologies, comprehensive centers for stem cell science and regenerative medicine in Tabriz and Shiraz are inaugurated.
Secretary General of the Second National Festival and International Congress on Stem Cell and Regenerative Medicine:
The Festival of Stem Cell and Regenerative Medicine Is the Biggest Meeting of Activist in this Field of Science
In the field of modern sciences, Iran has an reasonable development which in the field of stem cells, nanotechnology and nuclear energy these developments are more significant and good future for these technologies are imaginable in Iran.
Opening of the First Research Center of Stem Cells and Regenerative Medicine in Alborz Province
the first research center of stem cells and regenerative medicine was inaugurated on April 5th by support of the council for development of stem cell sciences and technologies.
Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review
Novartis announced today that the US Food and Drug Administration (FDA) has accepted the companys Biologics License Application (BLA) filing and granted priority review for CTL019, an investigational chimeric antigen receptor T cell (CAR-T) therapy, in relapsed and refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL). This is the first BLA submission by Novartis for a CAR-T. The priority review designation is expected to shorten the anticipated review time by the FDA.
Sickle Cell Anemia Patient Cured by Gene Therapy
In a world first, a teenager with sickle cell disease achieved complete remission after an experimental gene therapy at Necker Childrens Hospital in Paris, researchers say.
Dr. Hamidieh:
Cell Processing and Basic Research Centers Should Be Close to Equipped Hospitals
Cell processing and basic research centers should be close to equipped hospitals in order to use research achievements in the field of stem cells and regenerative medicine and all research centers across the country should be taken it into consideration.
Vice President for Science and Technology :
Knowledge based economy make progress by bridging the gap between universities and community
A valuable step on the road towards the development of stem cell technology is started in universities and could make grow in this field of science in future.
First International Congress of Personalized Medicine
First International Congress of Personalized Medicine Was Held in Imam Khomeini Hospital Conference Center
Life expectancy forecast to exceed 90 years in coming decades
Study shows significant increase in lifespan, with South Korea top of league table and other countries not far behind
